Kate Larkin

Kate Larkin serves as a Member of the Board of Advisors at Trinity Life Sciences since January 2023. Prior to this role, Kate was the Senior Vice President for US Value, Access, and Pricing at Bristol-Myers Squibb from December 2017 to March 2021, where responsibilities included developing U.S. pricing strategies. Previously, Kate held several significant leadership positions at Amgen, including Vice President of US Pricing, Government Programs, and Commercial Economics from May 2013 to December 2017. During a long tenure at Bristol-Myers Squibb from November 2001 to May 2013, Kate advanced through roles such as Executive Director of Pricing & Reimbursement and others in sales and healthcare compliance. Kate's career in pharmaceuticals began at DuPont Pharmaceuticals in 1992, where initial roles included Account Executive and Field Sales. Educational credentials include an MBA in Finance from Widener University and a BA in Computer Science from La Salle University.